A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-64991524 in Healthy Participants
Clinical trial NCT03346122 · COMPLETED
Trial details
- NCT number
- NCT03346122
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-15
- Primary completion
- 2018-11-20
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.